Infant Bacterial Therapeutics AB (IBT) whose mission is to develop and commercialize pharmaceuticals for diseases affecting premature babies and BioConnection, a leading pharmaceutical Contract Manufa ...
Infant Bacterial Therapeutics AB ( ($SE:IBT.B) ) has shared an update. Infant Bacterial Therapeutics AB has partnered with ...
EU Commissioner for Enlargement Marta Kos looks at a production hall damaged after a recent Russian missile attack at DTEK's ...
Monster Beverage gains global market share with Ultra line, strong margins, emerging market penetration, and supply chain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback